What is Dr Florian Wernig's specialty?

Dr Florian Wernig is a consultant specialising in Endocrinology, Diabetes & Metabolism, with extensive experience in assessing and treating patients within this field.

Which conditions and treatments does Dr Florian Wernig specialise in?

Dr Florian Wernig is a endocrinologist who provides assessment and treatment for Polycystic ovary syndrome (PCOS), Adrenal gland disorders, Hyperparathyroidism, Thyroid disorders, Neuroendocrine tumours and Pituitary tumours. During your consultation, you will be informed of the most suitable options following a personalised evaluation.

How many years of experience does Dr Florian Wernig have?

Dr Florian Wernig has 26 years of professional experience as a consultant endocrinologist, providing specialist assessment and treatment in this medical field.

What do patients say about Dr Florian Wernig?

Patients give a rating of 4.9 out of 5 to Dr Florian Wernig, a score considered excellent. This average is based on 39 verified patient reviews, reflecting the experience of those who have attended an appointment.

Are Dr Florian Wernig's reviews verified?

Yes. All Dr Florian Wernig's reviews come from verified patients who have attended either an in-person or an e-Consultation appointment. We use a system that ensures authenticity and prevents fake reviews. Some profiles may also display reviews from other platforms, which follow their own verification policies, with the source always clearly indicated.

Where does Dr Florian Wernig practise?

Dr Florian Wernig practices in the following locations: W1G Marylebone London at Devonshire Place West London at Cromwell Road West London at Sydney Street West London at Fulham Palace Road West London at Du Cane Road In-person consultations are available at these locations as a Endocrinology, Diabetes & Metabolism.

How can I book an appointment with Dr Florian Wernig?

You can book an appointment with Dr Florian Wernig directly from this page by selecting the time that suits you best. Alternatively, you can call the phone number shown if you prefer personalised assistance.

Does Dr Florian Wernig see NHS patients?

Many specialists featured on Top Doctors also hold NHS positions. However, appointments arranged for Dr Florian Wernig through this platform are private, either self-pay or covered by private medical insurance.

Does Dr Florian Wernig offer private appointments?

Yes, Dr Florian Wernig offers private appointments for patients seeking flexible and direct access to a consultant endocrinologist.

Does Dr Florian Wernig offer online consultations?

At the moment, Dr Florian Wernig does not offer online consultations. You can book an in-person appointment from this page or call +44 02070316778. When calling, please mention that you are a Top Doctors patient.

Does Dr Florian Wernig accept insurance?

Dr Florian Wernig works with the following private medical insurance providers: Bupa, AXA, AVIVA, Cigna, WPA, Simply Health, Allianz, CS Healthcare, Vitality, The Exeter Friendly, Pru Health, Groupama, April, Freedom, National Assurance, General Medical, Saga, Healix, Legal & General Insurance, Health-online, Benenden Health , Alliance Health Group, Police Mutual, Aetna, Tricare, Asia Medical Assistance, AIG, Health Now, Humanis, International SOS, Standard Life and Bupa Global. If your insurer is not listed, you may contact the practice directly to confirm your coverage.

What is Dr Florian Wernig's availability?

Dr Florian Wernig's availability depends on the appointment slots open at any given time. On this page, you can check current availability, and if no slots are shown, you can request an appointment or contact the practice directly.

What payment methods does Dr Florian Wernig offer?

You can pay for your consultation with Dr Florian Wernig using the following methods: Self-paying.

What languages does Dr Florian Wernig speak?

Dr Florian Wernig is a endocrinologist who offers consultations in German, English, French and Italian.

How is Dr Florian Wernig selected to appear on this platform?

All doctors listed on Top Doctors, including Dr Florian Wernig, undergo our rigorous selection process. Only one in five specialists meets the required standards to be included.

Dr Florian Wernig

GMC: 6064017

4.939reviewsReview

Expert in:

Pituitary tumours

Adrenal gland disorders

Thyroid disorders

Neuroendocrine tumours

Hyperparathyroidism

Polycystic ovary syndrome (PCOS)

Professional statement

Dr Florian Wernig is a leading consultant endocrinologist based in London and sees patients at The London Clinic, Bupa Cromwell Hospital, HCA Outpatient and Diagnostic Centre, Charing Cross Hospital and Hammersmith Hospital. He also sees patients at Imperial College Healthcare NHS Trust. Dr Wernig has extensive knowledge in all aspects of endocrinology, however, he has a particular interest in pituitary disease, adrenal disorders, neuroendocrine tumours, thyroid disorders and thyroid cancer.

Dr Wernig has a strong basis in research and has trained at some of the best London institutions. He completed his MD in molecular endocrinology at the University of Innsbruck. He carried out research at the Austrian Academy of Sciences and at St George's University of London. Dr Wernig's postgraduate training was in endocrinology in general internal medicine in London on the Imperial/Hammersmith rotation. Dr Wernig is an Honorary Clinical Senior Lecturer at Imperial College.

Dr Wernig remains actively involved in research and is the lead investigator for several international multicentre clinical trials. Dr Wernig is a fellow of the Royal College of Physicians and a member of the British Society of Endocrinology and the European Society for Endocrinology.

Clinics

The London Clinic
W1G Marylebone London, Devonshire Place, W1G 6HL
Medical insurances accepted
I'm paying for myself
Bupa
AXA
AVIVA
Cigna
WPA
Simply Health
Allianz

Credentials

Professional experience

26 years of experience
Consultant Endocrinologist, Imperial College Healthcare NHS Trust
Consultant Endocrinologist, The London Clinic
Consultant Endocrinologist, Bupa Cromwell Hospital
Consultant Endocrinologist, The Lister Hospital

Subspecialties

Pituitary disorders
Prolactin
Acromegaly
Cushing's disease
Hypophysitis
IgG4 disease
Adrenocortical cancer
Infertility
Hirsutism
PCOS
Calcium disorders
Osteoporosis
Thyroid disease
Thyroid cancer
Neuroendocrine tumours
Multiple endocrine neoplasia
Type I and type II diabetes

Professional memberships

Endocrine Society
British Society of Endocrinology
European Society for Endocrinology

Education

Fellowship at the Royal College of Physicians
Doctor of Medicine, University of Innsbruck, Austria (2000)
Endocrinology training at leading tertiary referral centres based at Hammersmith and Charing Cross Hospitals in central London

Teaching posts

Honorary Clinical Senior Lecturer, Imperial College London (2015 - present)

Publications and conferences

Boharoon H, Tomlinson J, Limback-Stanic C, Gontsorova A, Martin N, Hatfield E, Meeran K, Nair R, Mendoza N, Levy J, McAdoo S, Pusey C, Wernig F. A Case series of Patients with Isolated IgG4- related Hypophysitis treated with Rituximab. Journal of the Endocrine Society. Accepted Maunscript, published 21 April 2020
Clarke S, Abbara A, Brewster R, Simmonard A, Eng PC, Phylactou M, Papadopoulou D, Izzi- Engbeaya D, Sam A, Wernig F, Jonauskyte E, Comninos A, Meeran K, Kelsey T, Dhillo W. CasePharacodynamic response to anti-thyroid drugs in Graves’ hyperthyroidism. Frontiers in Endocrinology. 12 May 2020.
Marques P, Caimari F, Hernandez-Ramirez LC, Collier D, Iacovazzo D, Ronaldson A, Magdid K, Lim CT, Stals K, Ellard S, Grossman AB, Korbonits M; FIPA Consortium: Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-Onset Pituitary Tumors. J Clin Endocrinol Metab. Jun 2020; 105(6)
Zaman S, Patel B, Glynne P, Vanderpump M, Alsafi A, Khan S, Flora R Palazzo F, Wernig F: A rare cause of severe Cushing’s syndrome. Endocrinol Diabetes Metab Case Rep. Mar 13, 2020
Marques P, Stelmachowska-Banas M, Collier D, Wernig F, Korbonits M: Pachydermoperiostosis mimicking the acral abnormalities of acromegaly. Endocrine. Feb 2020; 67(2):499-500.
Sharma R, Wang WM, Yusuf S Evans J, Ramaswami R, Wernig F, Frilling A, Mauri F, Al-Nahhas A, Aboagye EO, Barwick TD: 68Ga-D”OTATATE PET/CT parameters predict response to peptide receptor radionuclide therapy in neuroendocrine tumours. Radiother Oncol. Dec 2019; 141:108-115
Poo SX, Tham CSW, Smit C, Lee J, Cairns T, Galliford J, Hamdulay S, Jacyna M, Levy JB, McAdoo SP, Roufosse C, Wernig F, Mason JC, Pusey CD, Tam FWK, Tomlinson JAP: IgG4-related disease in a multi-ethnic community:clinical characteristics and association with malignancy. QJM. Oct 2019; 112(10):763-769
Pearce SHS, Dayan C, Wraith DC, Barrell K, Olive N, Jansson L, Walker-Smit T, Carnegie C, Martin KF, Boelaert K, Gilbert J, Higham CE, Muller I, Murray RD, Perros P, Razvi S, Vaidya B, Wernig F, Kahaly GJ: Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves’ Hyperthyroidism: A Phase I Study. Thyroid. Jun 13 (2019)
Smith C, Hameed S, Rose GE, Wernig F: A 61 year old man with pancreatitis, pituitary dysfunction, and painful exophthalmos. BMJ, Feb 21 (2019)
Abbara A, Clarke S, Eng PC, Milburn J, Joshi D, Comninos AN, Ramli R, Mehta A, Jones B, Wernig F, Nair R, Mendoza N, Sam AH, Hatfield E, Meeran K, Dhillo WS, Martin NM: Clinical and biochemical characteristics of patients presenting with pituitary apoplexy. Endocr Connect. Aug 23 (2018), pii 18-0255.
Maher M, Roncaroli F, Mendoza N, Meeran K, Canham N, Kosicka-Slawinska M, Bernhard B, Collier D, Drummond J, Skordilis K, Tufton N, Gontsarova A, Martin N, Korbonits M, Wernig F: A patient with a germline SDHB mutation presenting with an isolated pituitary macroprolactinoma. Endocrinol Diabetes Metab Case Rep. Jul 21 (2018), pii 18-0078.
Wernig F, Jayasena C, Dhillo, WS: Carcinoid syndrome and neuroendocrine tumours. Endocrine Cancer. Medicine 45:9 (2017),543-546
A novel somatic mutation implicates ATP6V0D1 in proinsulin processing Parizad Avari, Pei Chia Eng, Ming Hu, Runzhi Chen, Natalija Popovic, Constantin Polychronakos, Duncan Spalding, Guy A Rutter, Nick Oliver, Florian Wernig Journal of the Endocrine Society, bvac196, https://doi.org/10.1210/jendso/bvac196
Published 29 December 2022
ArTisaN trial protocol: a single Centre, open-label, phase II trial of the safety and efficacy of TheraSphere selective internal radiation therapy (SIRT) in the treatment of inoperable metastatic (liver) neuroendocrine neoplasia (NENs).
Sharma R, Slater S, Evans J, Martinez M, Ward C, Izadi H, Wernig F, Thomas R.BMC Cancer. 2022 Jul 20;22(1):800. doi: 10.1186/s12885-022-09859-9.
Late-night salivary cortisol and cortisone should be the initial screening test for Cushing's syndrome.
Mohamed RS, Abuelgasim B, Barker S, Prabhudev H, Martin NM, Meeran K, Williams EL, Darch S, Matthew W, Tan T, Wernig F.Endocr Connect. 2022 Jun 27;11(7):e220050. doi: 10.1530/EC-22-0050. Print 2022 Jul 1.
A Comparison of the Blood Glucose, Growth Hormone, and Cortisol Responses to Two Doses of Insulin (0.15 U/kg vs. 0.10 U/kg) in the Insulin Tolerance Test: A Single-Centre Audit of 174 Cases.
Yeoh P, Dwyer AA, Anghel E, Bouloux PM, Khoo B, Chew S, Wernig F, Carroll P, Aylwin SJB, Baldeweg SE, Drake W, Todd J, Mangena L, Grossman A.Int J Endocrinol. 2022 Feb 8;2022:7360282. doi: 10.1155/2022/7360282. eCollection 2022.
To block, or not to block … is it still the question? Effectiveness of alpha- and beta-blockade in phaeochromocytoma surgery: an institutional analysis.
Van Den Heede K, Paspala A, Chander N, Chidambaram S, Wernig F, Todd JF, DiMarco AN, Palazzo FF.Ann R Coll Surg Engl. 2022 Feb;104(2):138-143. doi: 10.1308/rcsann.2021.1077.
SDHC phaeochromocytoma and paraganglioma: A UK-wide case series.
Williams ST, Chatzikyriakou P, Carroll PV, McGowan BM, Velusamy A, White G, Obholzer R, Akker S, Tufton N, Casey RT, Maher ER, Park SM, Porteous M, Dyer R, Tan T, Wernig F, Brady AF, Kosicka-Slawinska M, Whitelaw BC, Dorkins H, Lalloo F, Brennan P, Carlow J, Martin R, Mitchell AL, Harrison R, Hawkes L, Newell-Price J, Kelsall A, Igbokwe R, Adlard J, Schirwani S, Davidson R, Morrison PJ, Chung TT, Bowles C, Izatt L.Clin Endocrinol (Oxf). 2022 Apr;96(4):499-512. doi: 10.1111/cen.14594. Epub 2021 Sep 24.
Utility of Cannulated Prolactin to Exclude Stress Hyperprolactinemia in Patients with Persistent Mild Hyperprolactinemia.
Almazrouei R, Zaman S, Wernig F, Meeran K.Clin Med Insights Endocrinol Diabetes. 2021 Jun 22;14:11795514211025276. doi: 10.1177/11795514211025276. eCollection 2021.
Alameri, M., Alnuaimi, A., Martin, N. M., Meeran, K., Gontsarova, A., Barwick, T. D., . . . Wernig, F. (2024). Pituitary hypophysitis in granulomatosis with polyangiitis (GPA): a case series.. Pituitary. doi:10.1007/s11102-023-01378-5 Wernig, F., Dunin-Borkowska, A., Frisiras, A., Khoo, B., Todd, J., Di Marco, A., . . . Alsafi, A. (2024). Adrenal Vein Sampling: Does the Location of the Non-adrenal Venous Sample Matter?. Cardiovasc Intervent Radiol. doi:10.1007/s00270-023-03647-z Chidambaram, S., Van Den Heede, K., Damji, S., Meeran, K., Todd, J., Wernig, F., . . . Di Marco, A. N. (2023). The Impact of Obesity on the Resolution of Hypertension Following Adrenalectomy for Primary Hyperaldosteronism. WORLD JOURNAL OF SURGERY, 47(9), 2188-2196. doi:10.1007/s00268-023-07021-5 Mills, E. G., Palazzo, F. F., Leen, E., & Wernig, F. (2023). Emerging Potential of Microwave Ablation for Primary Aldosteronism Resulting From Unilateral Aldosterone-producing Adenoma.. JCEM Case Rep, 1(4), luad077. doi:10.1210/jcemcr/luad077 Avari, P., Eng, P. C., Hu, M., Chen, R., Popovic, N., Polychronakos, C., . . . Wernig, F. (2023). A Novel Somatic Mutation Implicates ATP6V0D1 in Proinsulin Processing. JOURNAL OF THE ENDOCRINE SOCIETY, 7(3), 5 pages. doi:10.1210/jendso/bvac196 Sharma, R., Slater, S., Evans, J., Martinez, M., Ward, C., Izadi, H., . . . Thomas, R. (2022). ArTisaN trial protocol: a single Centre, open-label, phase II trial of the safety and efficacy of TheraSphere selective internal radiation therapy (SIRT) in the treatment of inoperable metastatic (liver) neuroendocrine neoplasia (NENs). BMC CANCER, 22(1), 7 pages. doi:10.1186/s12885-022-09859-9 Mohamed, R. S., Abuelgasim, B., Barker, S., Prabhudev, H., Martin, N. M., Meeran, K., . . . Wernig, F. (2022). Late-nigh salivary cortisol and cortisone should be the initial screening test for Cushing's syndrome. ENDOCRINE CONNECTIONS, 11(7), 7 pages. doi:10.1530/EC-22-0050 Almazrouei, R., Zaman, S., Wernig, F., & Meeran, K. (2021). Utility of Cannulated Prolactin to Exclude Stress Hyperprolactinemia in Patients with Persistent Mild Hyperprolactinemia. CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 14, 7 pages. doi:10.1177/11795514211025276 Williams, S. T., Chatzikyriakou, P., Carroll, P. V., McGowan, B. M., Velusamy, A., White, G., . . . Izatt, L. (2022). SDHC phaeochromocytoma and paraganglioma: A UK-wide case series. CLINICAL ENDOCRINOLOGY, 96(4), 499-512. doi:10.1111/cen.14594 Yeoh, P., Dwyer, A. A., Anghel, E., Bouloux, P. M., Khoo, B., Chew, S., . . . Grossman, A. (2022). A Comparison of the Blood Glucose, Growth Hormone, and Cortisol Responses to Two Doses of Insulin (0.15 U/kg vs. 0.10 U/kg) in the Insulin Tolerance Test: A Single-Centre Audit of 174 Cases. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2022, 8 pages. doi:10.1155/2022/7360282 Van Den Heede, K., Paspala, A., Chander, N., Chidambaram, S., Wernig, F., Todd, J. F., . . . Palazzo, F. F. (2022). To block, or not to block … is it still the question? Effectiveness of alpha- and beta-blockade in phaeochromocytoma surgery: an institutional analysis.. Ann R Coll Surg Engl, 104(2), 138-143. doi:10.1308/rcsann.2021.1077 Van Den Heede, K., Paspala, A., Chander, N., Chidambaram, S., Wernig, F., Todd, J. F., . . . Palazzo, F. F. (2022). To block, or not to block ... is it still the question? Effectiveness of alpha- and beta-blockade in phaeochromocytoma surgery: an institutional analysis. ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 104(2), 138-143. doi:10.1308/rcsann.2021.0133 Wernig, F., Jayasena, C. N., & Dhillo, W. S. (2021). Carcinoid syndrome and neuroendocrine tumours. Medicine, 49(9), 544-547. doi:10.1016/j.mpmed.2021.06.004 Zaman, S., Almazrouei, R., Sam, A. H., DiMarco, A. N., Todd, J. F., Palazzo, F. F., . . . Wernig, F. (2021). Synacthen Stimulation Test Following Unilateral Adrenalectomy Needs to Be Interpreted With Caution. FRONTIERS IN ENDOCRINOLOGY, 12, 7 pages. doi:10.3389/fendo.2021.654600
Mohamed, R. S., Abuelgasim, B., Barker, S., Prabhudev, H., Martin, N. M., Meeran, K., . . . Wernig, F. (2022). Late-nigh salivary cortisol and cortisone should be the initial screening test for Cushing's syndrome. ENDOCRINE CONNECTIONS, 11(7), 7 pages. doi:10.1530/EC-22-0050
Sharma, R., Slater, S., Evans, J., Martinez, M., Ward, C., Izadi, H., . . . Wernig, F, Thomas, R. (2022). ArTisaN trial protocol: a single Centre, open-label, phase II trial of the safety and efficacy of TheraSphere selective internal radiation therapy (SIRT) in the treatment of inoperable metastatic (liver) neuroendocrine neoplasia (NENs). BMC CANCER, 22(1), 7 pages. doi:10.1186/s12885-022-09859-9
Avari, P., Eng, P. C., Hu, M., Chen, R., Popovic, N., Polychronakos, C., . . . Wernig, F. (2023). A Novel Somatic Mutation Implicates ATP6V0D1 in Proinsulin Processing. JOURNAL OF THE ENDOCRINE SOCIETY, 7(3), 5 pages. doi:10.1210/jendso/bvac196
Mills, E. G., Palazzo, F. F., Leen, E., & Wernig, F. (2023). Emerging Potential of Microwave Ablation for Primary Aldosteronism Resulting From Unilateral Aldosterone-producing Adenoma.. JCEM Case Rep, 1(4), luad077. doi:10.1210/jcemcr/luad077
Chidambaram, S., Van Den Heede, K., Damji, S., Meeran, K., Todd, J., Wernig, F., . . . Di Marco, A. N. (2023). The Impact of Obesity on the Resolution of Hypertension Following Adrenalectomy for Primary Hyperaldosteronism. WORLD JOURNAL OF SURGERY, 47(9), 2188-2196. doi:10.1007/s00268-023-07021-5
Wernig, F., Dunin-Borkowska, A., Frisiras, A., Khoo, B., Todd, J., Di Marco, A., . . . Alsafi, A. (2024). Adrenal Vein Sampling: Does the Location of the Non-adrenal Venous Sample Matter?. Cardiovasc Intervent Radiol. doi:10.1007/s00270-023-03647-z
Alameri, M., Alnuaimi, A., Martin, N. M., Meeran, K., Gontsarova, A., Barwick, T. D., . . . Wernig, F. (2024). Pituitary hypophysitis in granulomatosis with polyangiitis (GPA): a case series.. Pituitary. doi:10.1007/s11102-023-01378-5

Languages spoken

German
English
French
Italian

Registration number: 6064017

Reviews

All reviews are from real patients and have been verified by our Customer Service department to ensure they meet our guidelines. Rules of the service

39 reviews

4.9

Review this doctor

Would you recommend this doctor?
Treatment of the doctor
Treatment of the staff
Waiting time
Condition of facilities

4 days on - nearly 5- plus the week-end, so 7 days since blood tests. And NO results. Go to the NHS, not this doctor. And when we will get results... he can only comment 10 days on. This is for a VERY serious issue with Hypoglycemia. Go to the NHS
29 April 2025
D.S.
Verified patient
Very professional and knowledgeable. Dr Wernig took his time to listen to my symptoms and gave me many options to consider. He also has a very holistic approach to treatment. I would definitely recommend him to friends and family.
7 June 2022
P.S.
Verified patient
Dr Wernig filled me with full confidence and indeed four weeks on the recommended surgery has been completed to full satisfaction.
7 June 2022
P.C.
Verified patient
I was seen very quickly by Dr Wernig, who gave a very clear explanation of the problem and the proposed solution. It was a very satisfying consultation.
7 June 2022
D.M.
Verified patient
Dr Wernig was very professional whilst at the same time warm and compassionate. He is a good communicator and took the time to listen as well as inform. I left my consultation feeling as though I’d been heard and with a clearer idea of the path forward.
7 June 2022
C.G.
Verified patient
It was excellent reception and excellent attention and strategy. He is highly knowledgeable doctor. Thank you
7 February 2022
T.L.
Verified patient
I would highly recommend Dr. Wernig. He took very good care of me and explained all options, treatments. His communication was perfect.
7 February 2022
M.K.
Verified patient
I highly recommend Dr Florian. His manners, attention to detail and his vast experience is paramount to my confidence. He listens, takes notes and offers a solution. I trust Dr Wernig and feel optimistic my surgery will be a success!
25 July 2021
D.R.
Verified patient
Dr Wernig is a true professional with a very personable approach to patients.He listens and does think things through on individual basis and not 'by the book'.It is clinical approach at its best...
25 July 2021
A.G.
Verified patient
A very caring and well prepared doctor. You are in good hand
24 July 2021
P.S.
Verified patient

Treatments

The doctor is expert in

Adrenal gland disorders

Hyperparathyroidism

Neuroendocrine tumours

Pituitary tumours

Polycystic ovary syndrome (PCOS)

Thyroid disorders

The doctor also specialises in:

Acromegaly

Adrenal glands cancer

Cushing's syndrome

DEXA scan

Diabetes

Diseases of the pituitary and hypothalamus

Endocrine test

Graves' disease

Hirsutism

Hormone replacement therapy (HRT)

Frequently Asked Questions

The doctor, or where applicable the hospital or medical centre in which the doctor provides services, undertakes to keep the information relating to the prices of services published on their profile on the Top Doctors platform up to date at all times, ensuring that such prices correspond to those effectively charged to patients. In the event of any discrepancy between the published price and the price ultimately charged to the patient, the doctor and/or the relevant hospital or medical centre shall be solely liable towards the patient and towards Top Doctors for any claim or financial difference arising therefrom.

Request now: The appointment management service is free

Appointment subject to confirmation